Literature DB >> 33843059

Roles of FAM134B in diseases from the perspectives of organelle membrane morphogenesis and cellular homeostasis.

Luoyi Zhu1,2,3, Xinxia Wang1,2,3, Yizhen Wang1,2,3.   

Abstract

Family with sequence similarity 134 member B (FAM134B)/RETREG1/JK1 is a novel gene with recently reported roles in various diseases. Understanding the function and mechanism of action of FAM134B is necessary to develop disease therapies. Notably, emerging data are clarifying the molecular mechanisms of FAM134B function in organelle membrane morphogenesis and the regulation of signaling pathways, such as the Wnt and AKT signaling pathways. In addition, transcription factors, RNA N6 -methyladenosine-mediated epigenetic regulation, microRNA, and small molecules are involved in the regulation of FAM134B expression. This review comprehensively considers recent studies on the role of FAM134B and its potential mechanisms in neurodegenerative diseases, obesity, viral diseases, cancer, and other diseases. The functions of FAM134B in maintaining cell homeostasis by regulating Golgi morphology, endoplasmic reticulum autophagy, and mitophagy are also highlighted, which may be the underlying mechanism of FAM134B gene mutation-induced diseases. Moreover, the molecular mechanisms of the FAM134B function during numerous biological processes are discussed. This review provides novel insights into the functions and mechanisms of FAM134B in various diseases, which will inform the development of effective drugs to treat diseases.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  ER-phagy; FAM134B; Golgi apparatus; HSAN ⅡB; cancer; mitophagy; obesity; signal pathways

Year:  2021        PMID: 33843059     DOI: 10.1002/jcp.30377

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  2 in total

1.  The crystal structure of the FAM134B-GABARAP complex provides mechanistic insights into the selective binding of FAM134 to the GABARAP subfamily.

Authors:  Junfeng Zhao; Zhiwei Li; Jianchao Li
Journal:  FEBS Open Bio       Date:  2021-12-09       Impact factor: 2.693

2.  Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development.

Authors:  Shuhang Wang; Yuqi Yang; Lu Li; Peiwen Ma; Yale Jiang; Minghui Ge; Yue Yu; Huiyao Huang; Yuan Fang; Ning Jiang; Huilei Miao; Hao Guo; Linlin Yan; Yong Ren; Lichao Sun; Yan Zha; Ning Li
Journal:  Vaccines (Basel)       Date:  2022-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.